Exchange: NYSE
Industry: Medical Labs & Research
Last Trade: 4:00 PM ET 2/9/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.73 | 0.56 | 30.36 |
| EPS, GAAP | 0.34 | 0.45 | -24.44 |
| Consensus Estimate | 0.73 | 0.53 | 37.74 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 2.70 | 2.70 | 0.00 |
| EPS, GAAP | 2.16 | 1.05 | 105.71 |
| Consensus Estimate | 2.66 | NA | NA |
| CVD | Industry Average | |
| P/E (TTM) | 21.77 | 82.20 |
| P/E (Forward) | 17.68 | 18.20 |
| PEG Ratio | 1.43 | 1.21 |
| Price/Sales | 1.28 | 1.74 |
| Beta | 1.06 | 0.75 |
| 8:58 AM | 1/26/2012 | US STOCK FUTURES: HOT STOCKS TO WATCH |
| 6:34 AM | 1/26/2012 | US STOCK FUTURES: HOT STOCKS TO WATCH |
| 2/4/2012 | Potential M&A Targets in Contract Research (Barrons.com) |
| 1/26/2012 | Just the facts, Fool. (The Motley Fool) |
| 1/13/2012 | Covance Margins Seen Slipping (Barrons.com) |
| 12/14/2011 | All cash flow is not created equal. (The Motley Fool) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)
